IRIS
MONTAGNANI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.718
NA - Nord America 14.617
AS - Asia 7.262
SA - Sud America 1.447
AF - Africa 245
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 19
Totale 42.341
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.301
IT - Italia 4.548
RU - Federazione Russa 4.179
GB - Regno Unito 2.883
CN - Cina 2.374
SG - Singapore 2.334
IE - Irlanda 2.068
DE - Germania 1.270
BR - Brasile 1.232
SE - Svezia 913
HK - Hong Kong 652
FR - Francia 648
FI - Finlandia 641
UA - Ucraina 636
VN - Vietnam 563
KR - Corea 377
IN - India 265
NL - Olanda 256
CA - Canada 182
ES - Italia 166
PL - Polonia 95
AT - Austria 91
BD - Bangladesh 86
TR - Turchia 84
AR - Argentina 82
MX - Messico 78
ZA - Sudafrica 75
IR - Iran 70
BE - Belgio 67
IQ - Iraq 59
CZ - Repubblica Ceca 57
JP - Giappone 54
CI - Costa d'Avorio 46
PK - Pakistan 43
ID - Indonesia 40
EC - Ecuador 32
AE - Emirati Arabi Uniti 28
CH - Svizzera 28
UZ - Uzbekistan 28
LT - Lituania 26
SA - Arabia Saudita 26
AU - Australia 24
CO - Colombia 24
PH - Filippine 23
EG - Egitto 22
VE - Venezuela 20
MY - Malesia 19
IL - Israele 18
MA - Marocco 17
PE - Perù 17
EU - Europa 16
JO - Giordania 16
PT - Portogallo 16
AZ - Azerbaigian 14
CL - Cile 14
KE - Kenya 14
BG - Bulgaria 13
JM - Giamaica 13
DK - Danimarca 12
LV - Lettonia 12
NG - Nigeria 12
PY - Paraguay 12
RO - Romania 12
TN - Tunisia 12
UG - Uganda 12
AL - Albania 11
DZ - Algeria 10
ET - Etiopia 10
EE - Estonia 9
SK - Slovacchia (Repubblica Slovacca) 8
TW - Taiwan 8
BO - Bolivia 7
CR - Costa Rica 7
GR - Grecia 7
HR - Croazia 7
KZ - Kazakistan 7
NO - Norvegia 7
NP - Nepal 7
PA - Panama 7
TT - Trinidad e Tobago 7
LU - Lussemburgo 6
NZ - Nuova Zelanda 6
OM - Oman 6
RS - Serbia 6
SN - Senegal 6
AM - Armenia 5
CY - Cipro 5
GE - Georgia 5
LK - Sri Lanka 5
UY - Uruguay 5
BH - Bahrain 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
MD - Moldavia 4
MK - Macedonia 4
MN - Mongolia 4
SV - El Salvador 4
Totale 42.281
Salva come PNG Salva come JPEG
Città #
Dallas 4.103
Southend 2.391
Dublin 2.023
Singapore 1.423
Moscow 1.202
Chandler 1.113
Ashburn 993
Santa Clara 828
Beijing 672
Munich 666
Hong Kong 631
Fairfield 556
Milan 525
Siena 512
Jacksonville 507
Hefei 445
Helsinki 410
Seoul 366
Ann Arbor 365
Princeton 303
Los Angeles 300
Rome 296
New York 294
Woodbridge 282
Florence 242
Wilmington 242
Seattle 233
Cambridge 192
Nanjing 185
Dong Ket 182
Houston 182
Menlo Park 136
Ho Chi Minh City 134
Boardman 125
São Paulo 124
Buffalo 106
Shanghai 102
Málaga 93
The Dalles 90
Turku 88
Hanoi 82
San Mateo 82
Düsseldorf 79
Turin 77
Nuremberg 76
Chicago 73
London 68
Council Bluffs 64
Nanchang 63
Warsaw 63
Brussels 62
Bengaluru 61
Frankfurt am Main 61
Toronto 61
Dearborn 60
Lauterbourg 59
Naples 57
Redondo Beach 54
Bologna 53
Lancaster 53
Denver 52
Montreal 51
Portsmouth 50
Vienna 50
Stockholm 49
Tokyo 49
Brooklyn 48
Fremont 48
Abidjan 46
Atlanta 46
Brescia 46
San Diego 45
Shenyang 43
Chennai 41
Genoa 41
Guangzhou 41
Washington 40
Johannesburg 38
Lappeenranta 38
Phoenix 38
Rio de Janeiro 38
Poplar 35
San Francisco 35
Catania 34
Changsha 34
Orem 34
Redwood City 34
Tianjin 30
Amsterdam 28
Belo Horizonte 28
Boston 28
Mexico City 28
Palermo 28
Hebei 27
Messina 27
Brno 25
Columbus 25
Bari 24
Izmir 24
Padova 24
Totale 26.460
Salva come PNG Salva come JPEG
Nome #
Utilizzo di dalbavancina nella terapia delle infezioni osteoarticolari 1.243
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 604
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 549
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 543
A first update on mapping the human genetic architecture of COVID-19 541
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 534
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 461
MENINGITE VIRALE DA HHV7. DESCRIZIONE DI UN CASO IN ADULTO IMMUNOCOMPETENTE 456
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 435
Analisi di clonalità di isolati di Streptococcus pyogenes resistenti ai macrolidi: fluttuazioni della dinamica di popolazione negli ultimi 8 anni 381
Crisi comiziale generalizzata in giovane paziente proveniente dal Togo 367
Genetic mechanisms of critical illness in COVID-19 333
Analisi della sensibilità a penicillina in isolati comunitari di Streptococcus pneumoniae: implicazioni cliniche in relazione alle concentrazioni minime inibenti 333
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 331
An explainable model of host genetic interactions linked to COVID-19 severity 327
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 324
Peripheral biomarkers' panel for severe COVID-19 patients 292
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 289
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 288
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 283
Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce 282
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 281
Pathogen-sugar interactions revealed by universal saturation transfer analysis 274
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 273
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 271
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes 271
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 268
Mapping the human genetic architecture of COVID-19 268
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 262
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 257
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 257
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine 256
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 255
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 253
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region 253
Case Report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy 252
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 251
Strategie di vaccinazione anti-pneumococcica nel paziente adulto HIV-positivo: confronto fra vaccino coniugato 13-valente e vaccino polisaccaridico 23-valente 250
Evolution of macrolide resistance in streptococcus pyogenes over 14 years in an area of central Italy 249
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 246
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 241
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 237
Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature 237
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 235
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 232
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 230
Clinical and microbiological features of acute bacterialconjunctivitis at the primary eye care unit in a hospital of centralItaly 229
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 229
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 227
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 224
Valutazione microbiologica del rischio infettivo nella chirurgia della cataratta 223
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. 223
Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies 221
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 220
Prognostic bioindicators in severe COVID-19 patients 219
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 218
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 217
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 217
Clinical and microbiological features of acute bacterial conjunctivitis at the primary eye care unit in a hospital of central Italy 217
Antimicrobial Susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy 216
Approccio perinatale al neonato che ha presentato malessere fetale 215
Serial KL-6 measurements in COVID-19 patients 215
Clindamycin-resistant Streptococcus pneumoniae 214
ERADICAZIONE DI INFEZIONE DA HCV DOPO TRATTAMENTO DI 8 SETTIMANE CON GRAZOPREVIR/ELBASVIR: CASE REPORT 212
Descrizione di un'epidemia da Enterobacteriaceae multiresistenti in un'unità di terapia intensiva neonatale 211
Meningite postchirurgica e infezione di cute e tessuti molli da Acinetobacter baumannii extensively drug resistant (XDR) 208
Discovery of new Mycoplasma pneumoniae antigens by use of a whole genome lambda display library 207
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 207
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 206
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 203
Risposta immunitaria a lungo termine dopo vaccinazione antipneumococcica con vaccino coniugato 13-valente o vaccino polisaccaridico 23-valente in adulti HIV positivi 201
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 201
Resistenza ai beta-lattamici in Streptococcus pneumoniae: 10 anni di sorveglianza nell’area senese 200
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 198
Prevalence of M75 Streptococcus Pyogenes strains harboring slaa gene in patients affected by pediatric obstructive sleep apnea syndrome in Central Italy 197
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 197
PATOGENI COLONIZZANTI IL NASOFARINGE DI SOGGETTI HIV POSITIVI E HIV NEGATIVI 196
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 196
Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006 196
Evoluzione ed efficace controllo di un vasto focolaio epidemico nosocomiale da Klebsiella pneumoniae produttrice di carbapenemasi in un’area Neurochirurgica: lezioni apprese. 194
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 194
A complex outbreak of multiresistant Enterobacteriaceae producing the acquired AmpC-type beta-lactamase FOX-7 in a neonatal intensive care unit setting 194
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 193
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 191
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 190
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 190
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 188
Ridotta sensibilità a penicillina in Streptococcus pneumoniae: analisi microbiologica di ceppi di recente isolamento 187
Diagnosi di sarcoidosi in nuova diagnosi di HIV 187
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 186
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 185
Epidemiologia delle chemioresistenze di Streptococcus pneumoniae nell’area senese: 1992-1998 184
Casistica di malattia reumatica e glomerulonefrite poststreptococcica: patologie passate o riemergenti? 184
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 184
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents 184
WES profiling of COVID-19 184
Epidemiologia delle chemioresistenze di Streptococcus pneumoniae in una popolazione pediatrica della provincia di Siena 181
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 181
Sierotipizzazione, clonalità e chemiosensibilità di isolati invasivi di Streptococcus pneumoniae nell'area senese: basi per una corretta strategia vaccinale” 179
Sierotipizzazione di isolati invasivi di Streptococcus pneumoniae: utilità della PCR multiplex nella sorveglianza epidemiologica 179
Totale 26.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.708 0 0 0 0 0 244 72 324 351 162 221 334
2021/20222.498 185 264 142 176 152 89 113 124 130 206 308 609
2022/20234.308 250 458 509 519 364 711 228 375 351 171 208 164
2023/20244.411 141 114 404 291 213 977 1.262 171 71 205 235 327
2024/20259.396 392 415 948 436 1.039 703 774 673 901 443 856 1.816
2025/202614.692 1.383 2.745 3.376 2.742 3.910 536 0 0 0 0 0 0
Totale 43.103